Molecule
Brand orforglipron
9 recorded programs. No comparable monthly price is verified. See the record for advertised amounts and conditions.
US route An FDA-approved orforglipron product exists. Classification recorded October 2026. FDA source. All orforglipron forms.
Entries
More columns to the right? Scroll across the table to see all details.
| Entry | Provider | Form | Recorded price with its payment basis | Last verified | Link |
|---|---|---|---|---|---|
| EntryTR-1049 | ProviderCall-On-Doc | FormOral tablet | Recorded priceNo comparable monthly price | Last verifiedOctober 2026 | Record |
| EntryTR-1021 | ProviderGoodRx | FormOral tablet | Recorded price$149 Published figure · Introductory medication offer, 0.8 mg or 2.5 mg Introductory offer Initial payment not verified Only 0.8 mg or 2.5 mg; offer ends December 31, 2026. Care costs $39/month separately. | Last verifiedOctober 2026 | Record |
| EntryTR-1095 | ProviderJumpstartMD | FormOral · dosage form not recorded | Recorded priceNo comparable monthly price | Last verifiedOctober 2026 | Record |
| EntryTR-1133 | ProviderKlinic | FormOral tablet | Recorded priceNo comparable monthly price | Last verifiedOctober 2026 | Record |
| EntryTR-0388 | Providerknownwell | FormOral tablet | Recorded price$149 Published figure · Foundayo 0.8mg pill; manufacturer-reference monthly price Initial payment not verified Recurring price conditions not established Manufacturer-reference drug price, not a knownwell invoice. Clinical visits and prescription eligibility are separate; final pharmacy cost may differ. The $149 reference is the displayed 0.8mg option; higher strengths show different reference prices. | Last verifiedOctober 2026 | Record |
| EntryTR-1114 | ProviderLovely Meds | FormOral tablet | Recorded price$299 Published figure · Brand pill advertised starting rate, one-month supply Initial payment not verified Recurring price conditions not established Prescription and individual eligibility required. Advertised rate does not establish a complete payable invoice or renewal schedule. | Last verifiedOctober 2026 | Record |
| EntryTR-1116 | Providernäky | FormOral tablet | Recorded price$149 Published figure · Month 1 pill advertised dose-stage rate Initial payment not verified Recurring price conditions not established Brand pill prescription eligibility and provider-directed titration required. Medication rate is separate from the required $125/month care membership. No ongoing price is inferred from the initial dose. | Last verifiedOctober 2026 | Record |
| EntryTR-1105 | ProviderShapely | FormOral tablet | Recorded price$25 Published figure · Foundayo — Commercial-insurance medication floor Initial payment not verified Recurring price conditions not established Advertised conditional starting figure, not a verified selected recurring invoice. Insurance eligibility or self-pay pathway and dose may change price; separate care membership applies. | Last verifiedOctober 2026 | Record |
| EntryTR-0675 | ProviderZipHealth | FormOral tablet | Recorded price$149 Published figure · 0.8mg advertised starting price; partner invoice unverified Initial payment not verified Recurring price conditions not established Prescription and individual clinical eligibility required. Starting advertisement; selected dose and final invoice are not established. | Last verifiedOctober 2026 | Record |